Drug Insights

A Complete Guide to Searching Magnesium citrate on Synapse

11 February 2024
2 min read

Magnesium citrate is a type of small molecule drug that is a combination of magnesium and citric acid in a 1:1 ratio. It is approved for use in the exclusion of intestinal contents during colon examination and as a pretreatment laxative for abdominal surgery. Magnesium citrate is available under the trade names Magcorol and Tectlol. The drug is manufactured by RMJ Holdings and was first approved in Japan on April 28, 1973. Magnesium citrate works by attracting water to the intestine and promoting bowel movement, thus clearing the intestinal tract. It is commonly used for bowel preparation prior to colonoscopy or other medical procedures requiring a clear intestinal tract. Magnesium citrate is available over-the-counter as a liquid or tablet form,also used in the pill form as a magnesium dietary supplement. Click on the image below to begin the exploration journey of Magnesium citrate through the Synapse database!

图形用户界面, 文本, 应用程序, 电子邮件

描述已自动生成

You can search for the latest pharmaceutical information such as drugs, targets, patents, transactions, clinical results, etc. through the Synapse database. Come and experience it!

图形用户界面, 文本, 应用程序, 聊天或短信

描述已自动生成

Ascendis Pharma Launches YORVIPATH® for Adult Hypoparathyroidism in Germany and Austria
Latest Hotspot
3 min read
Ascendis Pharma Launches YORVIPATH® for Adult Hypoparathyroidism in Germany and Austria
11 February 2024
Ascendis Pharma unveils its second TransCon™ offering: YORVIPATH® hits markets in Germany and Austria, targeting chronic hypoparathyroidism in adults.
Read →
Using Synapse for Your Cefdinir Research: An Easy Guide
Drug Insights
2 min read
Using Synapse for Your Cefdinir Research: An Easy Guide
11 February 2024
Cefdinir, marketed under the brand name Omnicef, is a small molecule drug that acts as a penicillin-binding protein (PBP) inhibitor and a cell wall inhibitor.
Read →
FDA Approves NeuroBo Pharmaceuticals' Phase 1 Study of Obesity Drug DA-1726
Latest Hotspot
3 min read
FDA Approves NeuroBo Pharmaceuticals' Phase 1 Study of Obesity Drug DA-1726
11 February 2024
NeuroBo Pharmaceuticals has received approval from the FDA for a Phase 1 clinical study of DA-1726, a new drug aimed at managing obesity.
Read →
Accessing Fluconazole Information on Synapse: A Step-by-Step Approach
Drug Insights
2 min read
Accessing Fluconazole Information on Synapse: A Step-by-Step Approach
11 February 2024
Fluconazole is a small molecule drug used to treat various fungal infections. It is sold under the trade names Diflucan, Zoltec, and Loitin.
Read →
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.